NOLCA MED: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
NOLCA MED
Largest movements
- Cash +€11,104
up €11,104 (+421%), from €2,636 to €13,740
mainly Other debts (+€25,218) and Net result for the year (+€8,260)
- Tangible fixed assets -€7,991
down €7,991 (-100%), from €7,991 to €0
- Receivables within one year +€5,214
up €5,214 (+43.6%), from €11,948 to €17,162
of which Other amounts receivable: +€4,707
- Other debts +€25,218
new in 2025: €25,218
- Profit (loss) carried forward -€16,959
down €16,959 (-100%), from €16,959 to €0
- Gross operating margin -€653
down €653 (-3.1%), from €21,269 to €20,616
- Depreciation -€342
down €342 (-4.1%), from €8,333 to €7,991
- Taxes +€268
up €268 (+7.8%), from €3,428 to €3,696
- Other operating charges +€237
up €237 (+89.9%), from €263 to €500
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €22,739 | €31,081 | +€8,342 | +36.7% |
| Fixed assets | 21/28 | €7,991 | €0 | -€7,991 | -100% |
| Tangible fixed assets | 22/27 | €7,991 | €0 | -€7,991 | -100% |
| Furniture and vehicles | 24 | €7,991 | €0 | -€7,991 | -100% |
| Current assets | 29/58 | €14,748 | €31,081 | +€16,333 | +111% |
| Amounts receivable within one year | 40/41 | €11,948 | €17,162 | +€5,214 | +43.6% |
| Trade receivables | 40 | €4,118 | €4,625 | +€508 | +12.3% |
| Other amounts receivable | 41 | €7,831 | €12,537 | +€4,707 | +60.1% |
| Cash at bank and in hand | 54/58 | €2,636 | €13,740 | +€11,104 | +421% |
| Deferred charges and accrued income | 490/1 | €164 | €178 | +€14 | +8.7% |
| Total equity and liabilities | 10/49 | €22,739 | €31,081 | +€8,342 | +36.7% |
| Equity | 10/15 | €18,959 | €2,000 | -€16,959 | -89.5% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €16,959 | €0 | -€16,959 | -100% |
| Amounts payable | 17/49 | €3,780 | €29,081 | +€25,300 | +669% |
| Amounts payable within one year | 42/48 | €3,780 | €29,081 | +€25,300 | +669% |
| Trade debts | 44 | €82 | €166 | +€85 | +104% |
| Suppliers | 440/4 | €82 | €166 | +€85 | +104% |
| Taxes, remuneration and social security | 45 | €3,699 | €3,696 | -€3 | -0.1% |
| Taxes | 450/3 | €3,699 | €3,696 | -€3 | -0.1% |
| Other amounts payable | 47/48 | - | €25,218 | +€25,218 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €8,333 | €7,991 | -€342 | -4.1% |
| Other operating charges | 640/8 | €263 | €500 | +€237 | +89.9% |
| Gross operating margin | 9900 | €21,269 | €20,616 | -€653 | -3.1% |
| Operating profit (loss) | 9901 | €12,673 | €12,126 | -€547 | -4.3% |
| Financial income | 75/76B | €6 | - | -€6 | |
| Recurring financial income | 75 | €6 | - | -€6 | |
| Financial charges | 65/66B | €229 | €170 | -€59 | -25.8% |
| Recurring financial charges | 65 | €229 | €170 | -€59 | -25.8% |
| Profit (loss) for the period before taxes | 9903 | €12,449 | €11,956 | -€494 | -4.0% |
| Income taxes | 67/77 | €3,428 | €3,696 | +€268 | +7.8% |
| Profit (loss) for the period | 9904 | €9,022 | €8,260 | -€762 | -8.4% |
| Profit (loss) for the period to be appropriated | 9905 | €9,022 | €8,260 | -€762 | -8.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 22 October 2026 via checked.be.